Abstract
Clindamycin (7-chloro-7-deoxylincomycin-hydrochloride-monohydrate) is an antibiotic with a remarkable bacteriostatic and bactericidal activity against staphylococci [1, 4, 5, 8]. It may, therefore, be regarded as one of the drugs suited for therapy of staphylococcal osteomyelitis, especially after very good efficacy of Lincomycin was recorded in this disease. To confirm this assumption, however, the data on penetration of Clindamycin into the bone under conditions of routine clinical practice are needed above all. This study presents the preliminary results obtained in this respect.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
